SG Americas Securities LLC cut its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) by 62.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,598 shares of the company’s stock after selling 12,610 shares during the quarter. SG Americas Securities LLC’s holdings in Acadia Healthcare were worth $594,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. First Horizon Advisors Inc. increased its stake in shares of Acadia Healthcare by 153.9% in the 2nd quarter. First Horizon Advisors Inc. now owns 452 shares of the company’s stock worth $31,000 after acquiring an additional 274 shares in the last quarter. Point72 Hong Kong Ltd bought a new position in shares of Acadia Healthcare in the 1st quarter worth about $38,000. C M Bidwell & Associates Ltd. bought a new position in shares of Acadia Healthcare in the 2nd quarter worth about $39,000. James Investment Research Inc. bought a new position in shares of Acadia Healthcare in the 2nd quarter worth about $50,000. Finally, Wipfli Financial Advisors LLC bought a new position in shares of Acadia Healthcare in the 3rd quarter worth about $72,000. 99.79% of the stock is currently owned by institutional investors.
Acadia Healthcare Stock Performance
Shares of NASDAQ ACHC opened at $84.62 on Monday. The firm’s 50-day moving average price is $83.82 and its 200-day moving average price is $81.64. The company has a quick ratio of 1.30, a current ratio of 1.30 and a debt-to-equity ratio of 0.50. The company has a market cap of $7.70 billion, a PE ratio of 27.30, a PEG ratio of 1.97 and a beta of 1.26. Acadia Healthcare Company, Inc. has a 52-week low of $50.07 and a 52-week high of $89.85.
Analyst Ratings Changes
ACHC has been the subject of several research reports. Mizuho increased their price target on shares of Acadia Healthcare from $80.00 to $87.00 and gave the stock a “neutral” rating in a research note on Thursday, December 8th. Loop Capital raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the company from $90.00 to $95.00 in a research report on Monday, December 12th. Royal Bank of Canada cut their price objective on shares of Acadia Healthcare from $94.00 to $93.00 and set an “outperform” rating on the stock in a research report on Monday, December 12th. StockNews.com initiated coverage on shares of Acadia Healthcare in a research report on Wednesday, October 12th. They set a “hold” rating on the stock. Finally, UBS Group cut their price objective on shares of Acadia Healthcare to $96.00 in a research report on Friday, November 4th. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average target price of $89.90.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.
- Get a free copy of the StockNews.com research report on Acadia Healthcare (ACHC)
- CVS Health is Growing into an Integrated Healthcare Organization
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
- Which Wireless Stock Should You Buy in 2023?
- Is Virgin Galactic Stock Preparing for Lift-Off?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.